BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+32.57%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$9.65B
AUM Growth
+$9.65B
Cap. Flow
+$144M
Cap. Flow %
1.49%
Top 10 Hldgs %
77.89%
Holding
100
New
5
Increased
16
Reduced
3
Closed
6
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ELVN icon
76
Enliven Therapeutics
ELVN
$1.24B
$2.93M 0.03%
114,833
CMPX icon
77
Compass Therapeutics
CMPX
$466M
$2.87M 0.03%
1,557,630
WVE icon
78
Wave Life Sciences
WVE
$1.27B
$2.82M 0.03%
+344,063
New +$2.82M
MRSN icon
79
Mersana Therapeutics
MRSN
$34.8M
$2.05M 0.02%
1,086,115
NAMS icon
80
NewAmsterdam Pharma
NAMS
$2.8B
$1.61M 0.02%
96,711
-116
-0.1% -$1.93K
IPSC icon
81
Century Therapeutics
IPSC
$40.4M
$1.36M 0.01%
797,460
VTVT icon
82
vTv Therapeutics
VTVT
$49.4M
$1.32M 0.01%
97,314
JBIO
83
Jade Biosciences, Inc. Common Stock
JBIO
$245M
$1.31M 0.01%
628,939
PFE icon
84
Pfizer
PFE
$141B
$1.01M 0.01%
35,000
TARA icon
85
Protara Therapeutics
TARA
$125M
$982K 0.01%
536,832
ALGS icon
86
Aligos Therapeutics
ALGS
$75.1M
$719K 0.01%
83,055
-1,993,345
-96% -$9
BCRX icon
87
BioCryst Pharmaceuticals
BCRX
$1.74B
$576K 0.01%
75,778
PMVP icon
88
PMV Pharmaceuticals
PMVP
$82.1M
$480K 0.01%
322,024
FHTX icon
89
Foghorn Therapeutics
FHTX
$298M
$419K ﹤0.01%
45,027
ACRV icon
90
Acrivon Therapeutics
ACRV
$42.2M
$370K ﹤0.01%
52,885
TYRA icon
91
Tyra Biosciences
TYRA
$657M
$249K ﹤0.01%
10,607
SRZNW icon
92
Surrozen, Inc. Warrant
SRZNW
$71.9K
$8.58K ﹤0.01%
833,333
ADAP
93
Adaptimmune Therapeutics
ADAP
$13.9M
-2,343,695
Closed -$2.28M
CERE
94
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
-683,588
Closed -$28M
TLIS
95
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
-508,323
Closed -$4.4M
ACHL
96
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
-1,108,767
Closed -$904K
SAGE
97
DELISTED
Sage Therapeutics
SAGE
-171,026
Closed -$1.86M
ATHA icon
98
Athira Pharma
ATHA
$15.5M
-3,153,807
Closed -$8.36M